- Smoking Cessation Rate and Related Factors of Varenicline in Clinical Practice
-
Song B, Yun WS, Choi EY, Cheong YS, Park EW
- KMID: 2304312
- Korean J Fam Med.
- 2011 Feb;32(2):112-119.
- doi: 10.4082/kjfm.2011.32.2.112
BACKGROUND: Varenicline is recently known as smoking cessation medicine has no results of researches conducted in the actual practice settings except for incipient clinical trials. This research attempted to analyze... -
- CITED
-
- Close
- SHARE
-
- Close
- Adherence to Varenicline and Abstinence Rates for Quitting Smoking in a Private Health Promotion Center-Based Smoking Cessation Clinic
-
Lee JY, Kim MJ, Jun HJ, Kang M, Park AR, Oh DE, Choi YH, Hwang JH
- KMID: 2319816
- Tuberc Respir Dis.
- 2012 May;72(5):426-432.
BACKGROUND: Varenicline is an effective smoking cessation aid. However, smokers prescribed with varenicline do not always receive varenicline for 12 weeks, as recommended. This study analyzed the subjects who received... -
- CITED
-
- Close
- SHARE
-
- Close
- Compliance and Effectiveness of Smoking Cessation Program Started on Hospitalized Patients
-
Shin GH, Yi SW, Cheong YS, Park EW, Choi EY
- KMID: 2235104
- Korean J Fam Med.
- 2016 May;37(3):149-155.
- doi: 10.4082/kjfm.2016.37.3.149
BACKGROUND: Varenicline is now very useful medication for cessation; however, there is only little result of researches with varenicline for cessation of hospitalized patients. This research attempted to analyze the... -
- CITED
-
- Close
- SHARE
-
- Close
- Seven-Day Continuous Abstinence Rate from Smoking at 1, 2, or 3 Years after the Use of Varenicline
-
Kim JS, Jang JY, Park EH, Lee JY, Gu KM, Jung JW, Choi JC, Shin JW, Park IW, Choi BW, Kim JY
- KMID: 2320600
- Tuberc Respir Dis.
- 2015 Apr;78(2):92-98.
- doi: 10.4046/trd.2015.78.2.92
BACKGROUND: Varenicline, a selective partial agonist/antagonist of the alpha4beta2 nicotinic receptor, has proven effectiveness for smoking cessation by several randomized, controlled trials. Because few studies have evaluated the long-term efficacy... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Multi-modal Interventions for Smoking Cessation in a University Setting: A Short Course of Varenicline, Financial Incentives, E-mail and Short Message Service
-
Cheong YS, Ahn SH
- KMID: 2235671
- Korean J Fam Med.
- 2010 May;31(5):355-360.
- doi: 10.4082/kjfm.2010.31.5.355
BACKGROUND: Varenicline is known to have higher effect for smoking cessation than existing pharmacotherapies, including Bupropion and Nicotine replacement therapy, however, it can also bring about adverse effects such as... -
- CITED
-
- Close
- SHARE
-
- Close
- Smoking Cessation Strategies Targeting Specific Populations
-
Chun EM
- KMID: 2441724
- Tuberc Respir Dis.
- 2019 Jan;82(1):1-5.
- doi: 10.4046/trd.2017.0101
Quitting smoking helps smokers maintain their health and extend their lifespan by 10 or more years. Treatment strategies for smoking cessation should be tailored to individual smokers with special needs... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacotherapy for Smoking Cessation in Patients with Schizophrenia
-
Kim SJ, Jung DU, Kim YN
- KMID: 2410776
- Korean J Schizophr Res.
- 2018 Apr;21(1):21-27.
- doi: 10.16946/kjsr.2018.21.1.21
Schizophrenia is a major chronic mental illness with various symptoms that is often accompanied by substance use disorders. Patients with schizophrenia have a higher smoking rate than the general population... -
- CITED
-
- Close
- SHARE
-
- Close
- Craving and treatment in smoking
-
Kim MH, Min S
- KMID: 2190424
- J Korean Med Assoc.
- 2011 Apr;54(4):401-408.
- doi: 10.5124/jkma.2011.54.4.401
Craving has been well known to be the most important clinical phenomenon in smoking cessation treatment and one that physicians always encounter. For successful and prolonged abstinence, understanding, evaluation, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Effective Smoking-Cessation Strategies in Primary Care Setting
-
Chun EM
- KMID: 2269239
- Korean J Med.
- 2014 Sep;87(3):296-301.
- doi: 10.3904/kjm.2014.87.3.296
Smoking leads to nicotine addiction and serious health problems and smoking cessation can reduce the risk of developing smoking-related diseases and premature death. Smoking is a chronic disease that requires... -
- CITED
-
- Close
- SHARE
-
- Close
- Short-Term Success Rates of Smoking Cessation Support Programs and Factors Predicting Smoking Relapse: Using Data from a Smoking Cessation Clinic in a Hospital
-
Yu SH, Kim MJ, Jeon J, Park HK, Hwang HS, Park KY
- KMID: 2469482
- Korean J Fam Med.
- 2019 Nov;40(6):373-379.
- doi: 10.4082/kjfm.18.0094
BACKGROUND: Although the number of medical institutions running a smoking cessation clinic is on the rise, there remains a paucity of research on the long- and short-term success rates of... -
- CITED
-
- Close
- SHARE
-
- Close
- National Trends in Smoking Cessation Medication Prescriptions for Smokers With Chronic Obstructive Pulmonary Disease in the United States, 2007-2012
-
Kwak MJ, Kim J, Bhise V, Chung TH, Petitto GS
- KMID: 2424399
- J Prev Med Public Health.
- 2018 Sep;51(5):257-262.
- doi: 10.3961/jpmph.18.119
OBJECTIVES: Smoking cessation decreases morbidity and mortality due to chronic obstructive pulmonary disease (COPD). Pharmacotherapy for smoking cessation is highly effective. However, the optimal prescription rate of smoking cessation medications... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness of Smoking Cessation Using Motivational Interviewing in Patients Consulting a Pulmonologist
-
Lim G, Park I, Park S, Song S, Kim H, Kim S
- KMID: 2320517
- Tuberc Respir Dis.
- 2014 Jun;76(6):276-283.
BACKGROUND: We aimed to investigate the role of the physician in practice and the factors that influence the success rate of smoking cessation. METHODS: This study retrospectively analyzed 126 adult smokers... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean Treatment Guideline on Pharmacotherapy of Co-existing Symptoms and Antipsychotics-related Side Effects in Patients with Schizophrenia
-
Yun JY, Lee JS, Kang SH, Nam B, Lee SJ, Lee SH, Choi J, Kim CH, Chung YC
- KMID: 2462049
- Korean J Schizophr Res.
- 2019 Oct;22(2):21-33.
- doi: 10.16946/kjsr.2019.22.2.21
OBJECTIVES: The current study covers a secondary revision of the guidelines for the pharmacotherapy of schizophrenia issued by the Korean Medication Algorithm for Schizophrenia (KMAP-SCZ) 2001, specifically for co-existing symptoms... -
- CITED
-
- Close
- SHARE
-
- Close
